.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AA12_Ancestim.Ancestim .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AA12_Ancestim.Ancestim| name: | Ancestim |
| ATC code: | L03AA12 | route: | subcutaneous |
| n-compartments | 1 |
Ancestim is a recombinant human stem cell factor (rhSCF) developed to enhance hematopoietic stem cell mobilization in combination with filgrastim for hematopoietic stem cell transplantation. It is not currently approved for clinical use.
No published pharmacokinetic studies or peer-reviewed sources with quantitative pharmacokinetic parameters for ancestim were found. Estimates below are based on its biological class and known clinical use in combination with filgrastim in healthy volunteers.